Answers are grounded in this paper and cite their sources.
Mirror-image study shows significant decrease in ED visits for suicidality in TRD patients after ketamine treatment, suggesting vital intervention.
A new study published in the Journal of Clinical Psychiatry suggests that ketamine and esketamine may significantly reduce emergency department (ED) visits related to suicidality in individuals with treatment‐resistant depression (TRD). The six‐month mirror‐image study tracked patients before and after receiving acute treatment with either ketamine or esketamine, revealing a striking decline in suicidality‐associated ED utilization.
No takes yet. Share an insight, caveat, or question.
Valerie A. Canady (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: